Physician profile
Michael Green
NPI 1053414581
$947.30
in general payments reported to CMS, 2019-2025
9 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $171 · 2021: $144 · 2022: $123 · 2023: $129 · 2024: $82.07 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $491.26 | 2019-2025 | Clareon, Centurion, Clareon Panoptix Pro |
| Abbvie INC. | $115.60 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $68.88 | 2020-2021 | |
| Allergan, INC. | $65.51 | 2020-2022 | |
| Dompe US, INC. | $59.26 | 2025 | Oxervate |
| Coopervision INC. | $50.28 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $38.94 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.97 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $21.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.